Zucara Therapeutics Inc., a start-up company founded by The Centre for Drug Research and Development and TIAP (then MaRS Innovation), is developing the first once-daily therapeutic to prevent hypoglycemia in patients with diabetes. Preventing hypoglycemia will dramatically change diabetes disease management, thereby improving both patient health and quality of life.
